$CELC 在 ESMO Congress 2026 上公布了 VIKTORIA-1 研究 PIK3CA MT 队列的最新结果，该研究涉及 HR+/HER2- 晚期乳腺癌患者。#ESMO26

https://www.globenewswire.com/news-release/2026/10/24/3387663/0/en/celcuity-presents-updated-results-from-the-pik3ca-mt-cohort-of-the-phase-3-viktoria-1-study-in-patients-with-hr-her2-advanced-breast-cancer-at-the-esmo-congress-2026.html?_gl=1*1rbnumn*_up*MQ..*_ga*MTE0MDM0MDUwNi4xNzkyODMyNTA3*_ga_B6167QB2TF*czE3OTI4MzI1MDYkbzEkZzAkdDE3OTI4MzI1MTEkajU1JGwwJGgxMTkyMDA5OTc.*_ga_ERWPGTJ5X8*czE3OTI4MzI1MDYkbzEkZzAkdDE3OTI4MzI1MTEkajU1JGwwJGgw